» Articles » PMID: 8299631

Evidence of Oxidative Stress in Chronic Heart Failure in Humans

Overview
Journal Eur Heart J
Date 1993 Nov 1
PMID 8299631
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic heart failure (CHF) due to coronary artery disease (CAD) has been shown to be associated with increased plasma thiobarbituric reactive substances (TBARS) and reduced plasma thiol (PSH) concentrations, suggesting oxidative stress (OS). The aims of the present studies were (a) to determine whether OS is due to CAD or CHF per se and (b) to determine if a wider range of more specific markers of OS are abnormal in CHF. In the first study, two groups of patients (n = 15 each) were compared. Group 1 (11 male, mean age 56 years) had CHF due to CAD and group 2 (12 male, mean age 53 years) had non-CAD CHF. Median plasma TBARS in controls was 7.6 nmol.ml-1, 10.0 nmol.ml-1 in group 1 and 9.3 nmol.ml-1 in group 2 (P < 0.01 both groups vs control). Median PSH was 505 384 and 364 nmol.ml-1 (P < 0.05 and P < 0.01 vs control) respectively. Fifty-three patients with CHF were recruited in the second study. Malondialdehyde and PSH were 10.3 and 409 nmol.ml-1 respectively, compared to control values of 7.9 and 560 nmol.ml-1 (both P < 0.001). The median values for the following additional measures of OS in controls and patients were: erythrocyte superoxide dismutase 131 vs 114 U.l-1 (P = 0.005); caeruloplasmin oxidase 97 vs 197 U.l-1 (P < 0.01); erythrocyte glutathione 1.56 nmol.ml-1 vs 1.77 nmol.ml-1 (P < 0.02); plasma conjugated dienes 0.28 vs 0.33 optical density units (P = ns).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The potential roles of exosomes in pathological cardiomyocyte hypertrophy mechanisms and therapy: A review.

Zhang L, Xie F, Zhang F, Lu B Medicine (Baltimore). 2024; 103(17):e37994.

PMID: 38669371 PMC: 11049793. DOI: 10.1097/MD.0000000000037994.


Plasma cystine/methionine ratio is associated with left ventricular diastolic function in patients with heart disease.

Asakura J, Nagao M, Shinohara M, Nishimori M, Yoshikawa S, Iino T Heart Vessels. 2023; 38(12):1422-1430.

PMID: 37620665 DOI: 10.1007/s00380-023-02302-4.


Cardiovascular aging: from cellular and molecular changes to therapeutic interventions.

Vakka A, Warren J, Drosatos K J Cardiovasc Aging. 2023; 3(3).

PMID: 37274126 PMC: 10238104. DOI: 10.20517/jca.2023.09.


Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure.

Cvetkovic T, Saric S, Stefanovic N, Stojiljkovic V, Djordjevic B, Stojanovic D J Int Med Res. 2022; 50(12):3000605221139711.

PMID: 36564997 PMC: 9793051. DOI: 10.1177/03000605221139711.


Effects of perilipin-5 on lipid metabolism and high-sensitivity cardiac troponin I.

Ethem I, Hacioglu C Rev Assoc Med Bras (1992). 2022; 68(8):1011-1016.

PMID: 36134829 PMC: 9574996. DOI: 10.1590/1806-9282.20211377.